Home›Companies›Biotech & Pharma›Simplicia

Simplicia, Inc.

Drug discovery software for developers using evidence from traditional medicine and pharmacology.

No LinkedIn page we could confirm. Why?
Updated Nov 9, 2026·Latest SEC filing Aug 13, 2026·Suggest an edit

About Simplicia

Simplicia is a private company based in Boston, Massachusetts, incorporated in 2026 in Delaware. It has reported $600,000 raised in one offering on Form D since August 2026.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 31, 2026Aug 13, 2026$600,000of $1.5M target6$100KSAFEsRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Simplicia's Form D filed Aug 13, 2026.

JK
Josepha Kaminski
Executive officer and director
KA
Katherine Arline
President and director

Sources

  1. SECSimplicia, Inc. filing history